Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose
- PMID: 36559212
- PMCID: PMC9785504
- DOI: 10.3390/pharmaceutics14122718
Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose
Abstract
Over the past 20 years, the interest in Cannabis oily extracts for medicinal use compounded in pharmacy has consistently grown, along with the need to have preparations of adequate quality. Hot maceration (M) is the most frequently used method to compound oily solutions. In this work, we systematically studied the possibility of using an ultrasonic homogenizer and a sonotrode (US) as an alternative extraction method. Oily solutions were prepared using two available varieties of Cannabis for medicinal use, called FM2 and Bedrocan. All preparations resulted with an equivalent content in CBD and THC, with the advantage of a faster process using US. In particular, 10 min sonication at the amplitude optimized for the sonotrode used (2 or 7 mm) provides not statistically different total Δ9-tetrahydrocannabinol (M-FM2: 0.26 ± 0.02 % w/w; US-FM2: 0.19 ± 0.004 % w/w; M-Bedrocan: 1.83 ± 0.17 % w/w; US-Bedrocan: 1.98 ± 0.01 % w/w) and total cannabidiol (M-FM2: 0.59 ± 0.04 % w/w; US-FM2: 0.58 ± 0.01 % w/w) amounts extracted in refined olive oil. It can therefore be confirmed that sonotrode is an efficient and fast extraction technique and its use is without negative consequence on the solvent properties. Despite DSC evidencing that both maceration and sonication modify the Tonset and enthalpy of the event at about -10 °C, the qualitative characteristics of the oil remained constant for the two treatments and similar to the starting material.
Keywords: Bedrocan; DSC; FM2; lipophilic volatile carbonyl compounds; oil characterization; oxidized fatty acids; sonotrode; tocopherol.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ferber S.G., Namdar D., Hen-Shoval D., Eger G., Koltai H., Shoval G., Shbiro L., Weller A. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Curr. Neuropharmacol. 2020;18:87–96. doi: 10.2174/1570159X17666190903103923. - DOI - PMC - PubMed
-
- Guerrero-Alba R., Barragan-Iglesias P., González-Hernández A., Valdez-Moráles E.E., Granados-Soto V., Condés-Lara M., Rodríguez M.G., Marichal-Cancino B.A. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. Front. Pharmacol. 2019;9:1496. doi: 10.3389/fphar.2018.01496. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
